London Ambulance Service Experience of COVID-19

COVID-19 Clinical Trial

Official title:

London Ambulance Service Experience of COVID-19

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04372069
• Other study ID #: LAS-INT-2020-01
• Status: Active, not recruiting
• Start date: April 9, 2020
• Est. completion date: April 8, 2021

Study information

• Verified date: April 2020
• Source: London Ambulance Service NHS Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

COVID-19 presents a significant and unprecedented public health challenge which is placing enormous strain on global health services. In London, we have seen exponential growth in the number of cases of COVID-19 and significant public concern which has been felt across healthcare systems. The London Ambulance Service NHS Trust (LAS) is consistently experiencing its busiest days on record and is at the frontline of the response to COVID-19.

Whilst knowledge of the progression and clinical manifestations of the disease is improving, there is a lack of knowledge of how COVID-19 patients access and use emergency medical services (EMS), and what interventions are required to manage these patients in their prehospital phase. This knowledge is vital for the planning and delivery of EMS care as the pandemic develops.

Similarly, although evidence is emerging from the in-hospital setting about the toll of caring for COVID-19 patients, little is known about the effects on the mental wellbeing of EMS staff who are faced with considerable uncertainty when triaging, assessing and treating patients with limited access to support, resources or testing.

This mixed method study will have two parallel work packages:

Work package one will aim to rapidly improve knowledge of how patients with COVID-19 access and use EMS services. Patient records will be reviewed for patients who present to LAS and go on to receive a diagnosis of COVID-19. Characteristics and trends in these presentations will be reported to inform the ongoing planning and delivery of EMS care to these patients.

Work package two will explore, through questionnaires and interviews, the personal and professional impacts of triaging, assessing and treating patients who receive a diagnosis of COVID-19. This will inform the ongoing support requirements for EMS staff and provide evidence to support the planning for future pandemic disease outbreaks.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 40
• Est. completion date: April 8, 2021
• Est. primary completion date: April 8, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

WP1: Patients of any age who received a face to face assessment by an LAS clinician and for whom the LAS were subsequently informed tested positive for COVID-19.

WP2: Staff from the LAS who were involved in the care of a patient who tested positive for COVID-19.

Exclusion Criteria:

WP1: Patients who have previously written to the London Ambulance Service NHS Trust requesting that their data is not used for research purposes will be excluded from work package one.

Patients who do not receive a COVID19 diagnosis.

WP2: Staff who do not provide full informed consent to participate.

Related Conditions & MeSH terms

• COVID-19

Locations

Country	Name	City	State
United Kingdom	London Ambulance Service NHS Trust	London

Sponsors (2)

Lead Sponsor	Collaborator
London Ambulance Service NHS Trust	London School of Hygiene and Tropical Medicine

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Define the characteristics of patients with COVID-19 who are treated by the London Ambulance Service	The primary outcome of the study is to define the characteristics of patients with COVID-19 who are treated by the London Ambulance Service (WP1)	1 year
Secondary	Survival status of patients with COVID-19 who are treated by London Ambulance Service	To report the survival of patients with COVID-19 who are treated by London Ambulance Service (WP1)	1 year
Secondary	The personal and professional impacts on Emergency Medical Service staff of triaging, assessing and treating patients who later receive a diagnosis of COVID-19	To explore the personal and professional impacts on Emergency Medical Service staff of triaging, assessing and treating patients who later receive a diagnosis of COVID-19 (WP2)	1 year